Liu Andrew M F, Lo Rico K H, Wong Cecilia S S, Morris Christina, Wise Helen, Wong Yung H
Department of Biochemistry, Molecular Neuroscience Center, Biotechnology Research Institute, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China.
J Biol Chem. 2006 Nov 24;281(47):35812-25. doi: 10.1074/jbc.M605288200. Epub 2006 Sep 28.
Signal transducer and activator of transcription 3 (STAT3) can be stimulated by several G(s)-coupled receptors, but the precise mechanism of action has not yet been elucidated. We therefore examined the ability of Galpha(s)Q226L (Galpha(s)QL), a constitutively active mutant of Galpha(s), to stimulate STAT3 Tyr705 and Ser727 phosphorylations in human embryonic kidney 293 cells. Apart from Galpha(s)QL, the stimulation of Galpha(s) by cholera toxin or beta2-adrenergic receptor and the activation of adenylyl cyclase by forskolin, (Sp)-cAMP, or dibutyryl-cAMP all promoted both STAT3 Tyr705 and Ser727 phosphorylations. Moreover, the removal of Galpha(s) by RNA interference significantly reduced the beta2-adrenergic receptor-mediated STAT3 phosphorylations, denoting its capacity to regulate STAT3 activation by a G protein-coupled receptor. The possible downstream signaling molecules involved were assessed by using specific inhibitors and dominant negative mutants. Induction of STAT3 Tyr705 and Ser727 phosphorylations by Galpha(s)QL was suppressed by inhibition of protein kinase A, Janus kinase 2/3, Rac1, c-Jun N-terminal kinase (JNK), or phosphatidylinositol 3-kinase, and a similar profile was observed in response to beta2-adrenergic receptor stimulation. In contrast to the Galpha16-mediated regulation of STAT3 in HEK 293 cells (Lo, R. K., Cheung, H., and Wong, Y. H. (2003) J. Biol. Chem. 278, 52154-52165), the Galpha(s)-mediated responses, including STAT3-driven luciferase activation, were resistant to inhibition of phospholipase Cbeta. Surprisingly, Galpha(s)-mediated phosphorylation at Tyr705, but not at Ser727, was resistant to inhibition of c-Src, Raf-1, and MEK1/2 as well as to the expression of dominant negative Ras. Therefore, as with other Galpha-mediated activations of STAT3, the stimulatory signal arising from Galpha(s) is transduced via multiple signaling pathways. However, unlike the mechanisms employed by Galpha(i) and Galpha(14/16), Galpha(s) distinctively requires protein kinase A, JNK, and phosphatidylinositol 3-kinase for STAT3 activation.
信号转导子和转录激活子3(STAT3)可被多种G(s)偶联受体激活,但其确切作用机制尚未阐明。因此,我们研究了组成型活性突变体Gα(s)Q226L(Gα(s)QL)在人胚肾293细胞中刺激STAT3 Tyr705和Ser727磷酸化的能力。除了Gα(s)QL,霍乱毒素或β2 - 肾上腺素能受体对Gα(s)的刺激以及福斯可林、(Sp)-cAMP或二丁酰 - cAMP对腺苷酸环化酶的激活均促进了STAT3 Tyr705和Ser727的磷酸化。此外,通过RNA干扰去除Gα(s)显著降低了β2 - 肾上腺素能受体介导的STAT3磷酸化,表明其通过G蛋白偶联受体调节STAT3激活的能力。使用特异性抑制剂和显性负性突变体评估了可能涉及下游信号分子。抑制蛋白激酶A、Janus激酶2/3、Rac1、c - Jun氨基末端激酶(JNK)或磷脂酰肌醇3激酶可抑制Gα(s)QL诱导的STAT3 Tyr705和Ser727磷酸化,并且在β2 - 肾上腺素能受体刺激时也观察到类似情况。与Gα16在HEK 293细胞中介导的STAT3调节不同(Lo,R. K.,Cheung,H.,和Wong,Y. H.(2003)J. Biol. Chem. 278,52154 - 52165),Gα(s)介导的反应,包括STAT3驱动的荧光素酶激活,对磷脂酶Cβ的抑制具有抗性。令人惊讶的是,Gα(s)介导的Tyr705磷酸化,但不是Ser727磷酸化,对c - Src、Raf - 1和MEK1/2的抑制以及显性负性Ras的表达具有抗性。因此,与其他Gα介导的STAT3激活一样,Gα(s)产生的刺激信号通过多种信号通路转导。然而,与Gα(i)和Gα( /16)所采用的机制不同,Gα(s)独特地需要蛋白激酶A、JNK和磷脂酰肌醇3激酶来激活STAT3。